FDA Approved Products

Application #	Type	Sponsor	Notes	Product #	Drug Name	Form	Strength	Active Ingredient	Approval Date	Marketing Status	Reference Standard
214900	NDA	SCYNEXIS		001	BREXAFEMME	TABLET;ORAL	EQ 150MG BASE	IBREXAFUNGERP CITRATE	2021-06-01	Prescription	Yes